Home › Research › How common it is
Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature
Ward A, Tardiff S, Dye C, Arrighi HM.. Dementia and geriatric cognitive disorders extra, 2013-09-28
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background The purpose of this study was to summarize published estimates for conversion from mild cognitive impairment or amnestic mild cognitive impairment to Alzheimer's dementia. We carried out a systematic review of English language publications to identify cohort studies published since January 2006 that reported the risk or rate of conversion. Summary Thirty-two cohort studies were identified, of which 14 reported annualized conversion rates (ACRs). Conversions over 1 year ranged from 10.2 to 33.6% (5 studies, median: 19.0%), and over 2 years from 9.8 to 36.3% (7 studies, median: 18.6%). ACRs ranged from 7.5 to 16.5% (7 studies, median: 11.0%) per person-year for studies recruiting from clinics, and from 5.4 to 11.5% (7 studies, median: 7.1%) for community samples. Key message Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up.
What this study adds
Evidence grade: High
This is a pooled review. Across 32 cohort studies, conversion rates from mild cognitive impairment to Alzheimer's dementia varied widely, with annualized rates of about 7.5% to 16.5% in clinic samples and 5.4% to 11.5% in community samples. Reported effect size: 33.6%; 19.0%; 36.3%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M. (2013). Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dementia and geriatric cognitive disorders extra. https://doi.org/10.1159/000354370
Vancouver
Ward A, Tardiff S, Dye C, Arrighi HM. Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dementia and geriatric cognitive disorders extra. 2013. doi:10.1159/000354370. PMID: 24174927.
BibTeX
@article{ward2013-24174927,
author = {Ward, A. and Tardiff, S. and Dye, C. and Arrighi, H. M.},
title = {{Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature}},
journal = {Dementia and geriatric cognitive disorders extra},
year = {2013},
doi = {10.1159/000354370},
pmid = {24174927},
url = {https://doi.org/10.1159/000354370}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We carried out a systematic review of English language publications to identify cohort studies published since January 2006 that reported the risk or rate of conversion.
- Summary Thirty-two cohort studies were identified, of which 14 reported annualized conversion rates (ACRs).
- Conversions over 1 year ranged from 10.2 to 33.6% (5 studies, median: 19.0%), and over 2 years from 9.8 to 36.3% (7 studies, median: 18.6%).
- ACRs ranged from 7.5 to 16.5% (7 studies, median: 11.0%) per person-year for studies recruiting from clinics, and from 5.4 to 11.5% (7 studies, median: 7.1%) for community samples.
- Key message Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up.
Why it matters
Across 32 cohort studies, conversion rates from mild cognitive impairment to Alzheimer's dementia varied widely, with annualized rates of about 7.5% to 16.5% in clinic samples and 5.4% to 11.5% in community samples. This shows the range reported in the literature and does not test any treatment.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designsystematic review
- Effect size33.6%; 19.0%; 36.3%
- Evidence strengthHigh
How this study scored 61/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Dementia and geriatric cognitive disorders extra) |
| Journal's citation record | 0 / 4 | Dementia and Geriatric Cognitive Disorders Extra: journal h-index 52 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2013 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 6 / 7 | Cited 427 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 28.5 citations a year over 15 year(s) since 2013 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 20 other studies in this library |
| Still being cited | 3 / 4 | Cited 138 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Henry Michael Arrighi: h-index 33 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Janssen Alzheimer Immunotherapy Research & Development (United States): institution h-index 151 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24174927) |
| Free to read | 2 / 2 | Free to read |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1159/000354370
- PubMed: 24174927
- Original source →
- Free full text: Dementia and Geriatric Cognitive Disorders Extra →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 29.
Later studies that cite this one
20 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in How common it is from nearby years
Also in How common it is
80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.